S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
S&P 500   4,298.86 (+0.11%)
DOW   33,876.78 (+0.13%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
OTCMKTS:RDGL

Vivos (RDGL) Stock Forecast, Price & News

$0.05
0.00 (0.00%)
(As of 06/9/2023 ET)
Compare
Today's Range
$0.05
$0.06
50-Day Range
$0.05
$0.11
52-Week Range
$0.04
$0.12
Volume
333,556 shs
Average Volume
599,620 shs
Market Capitalization
$20.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

RDGL stock logo

About Vivos (OTCMKTS:RDGL) Stock

Vivos, Inc. is a radiation oncology medical device company. It is engaged in the development of its yttrium-90 based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. The firm's product, RadioGel, is an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals. The company was founded by James C. Katzaroff on December 23, 1994 and is headquartered in Richland, WA.

Receive RDGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vivos and its competitors with MarketBeat's FREE daily newsletter.

RDGL Stock News Headlines

America's Worst Nightmare: A Major Financial Crisis Looms
Something strange is happening in our financial system. UBS analysts predict over 50,000 retail locations may close soon. Retail giants like Walmart, Foot Locker, Bed Bath & Beyond, and Macy's are already downsizing their stores. Are you using the best technology to protect your money at all costs?
Dua Lipa's LBD Looked Like a Pair of Pants With Straps
Master the Market: Free Stock Analysis + Buy/Sell/Hold Signals!
Get a full report that tells you what a stock is really worth, how safe the stock is, and if the timing is right to buy the stock. Plus a definitive Buy, Sell, Hold recommendation.
Vivos Inc. Enhances its Intellectual Property Protection
RDGL Real-Time Quotes
Vivos Inc Initiates Isopet® Therapy in Horses
Vivos Inc. Expands IsoPet® Trademark Protection
See More Headlines

RDGL Price History

RDGL Company Calendar

Today
6/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Finance
Current Symbol
OTCMKTS:RDGL
Employees
1
Year Founded
N/A

Profitability

Net Income
$-2,470,000.00
Net Margins
-6,616.61%
Pretax Margin
-6,616.61%

Debt

Sales & Book Value

Annual Sales
$40,000.00
Book Value
($0.02) per share

Miscellaneous

Free Float
301,044,000
Market Cap
$20.24 million
Optionable
Not Optionable
Beta
1.68

Key Executives

  • Carlton M. Cadwell
    Chairman & Secretary
  • Michael K. Korenko
    President, Chief Executive Officer & Director
  • Michael H. Pollack
    Chief Financial Officer
  • Nigel Raymond Stevenson
    Chief Science Officer
  • David J. Swanberg
    Chief Technical Manager













RDGL Stock - Frequently Asked Questions

How have RDGL shares performed in 2023?

Vivos' stock was trading at $0.0444 at the beginning of the year. Since then, RDGL stock has increased by 23.4% and is now trading at $0.0548.
View the best growth stocks for 2023 here
.

Are investors shorting Vivos?

Vivos saw a decline in short interest during the month of May. As of May 15th, there was short interest totaling 47,300 shares, a decline of 25.5% from the April 30th total of 63,500 shares. Based on an average daily volume of 2,153,000 shares, the days-to-cover ratio is presently 0.0 days.
View Vivos' Short Interest
.

What is Vivos' stock symbol?

Vivos trades on the OTCMKTS under the ticker symbol "RDGL."

How do I buy shares of Vivos?

Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vivos' stock price today?

One share of RDGL stock can currently be purchased for approximately $0.05.

How much money does Vivos make?

Vivos (OTCMKTS:RDGL) has a market capitalization of $20.24 million and generates $40,000.00 in revenue each year.

How can I contact Vivos?

Vivos' mailing address is 719 JADWIN AVENUE, RICHLAND WA, 99352. The official website for the company is www.radiogel.com. The company can be reached via phone at (509) 736-4000 or via fax at 509-736-4007.

This page (OTCMKTS:RDGL) was last updated on 6/9/2023 by MarketBeat.com Staff

My Account -